Top 5 Performing Stocks To Invest In Right Now


Shares of Macy’s (NYSE:M) soared in November, rising more than 20% in the span of a few weeks due to growing optimism about its prospects. While the retailer posted weak earnings for the third quarter, it offered upbeat earnings guidance for Q4 and made significant progress in conjunction with its strategy to monetize underutilized real estate.

Macy’s stock performance, data by YCharts.

Yet in the month following Thanksgiving, Macy’s stock gave back virtually all of its gains. Investors appear to be worried about reports of weak sales and heavy discounting among department stores.


This focus on short-term results — or rumors about short-term results, to be more exact — is misplaced. Several important developments could drive Macy’s stock much higher over the next few years.

Store closures and cost cuts could bolster Macy’s profit margin

First, Macy’s plans to close about 100 stores next year. So far, the company has identified just a few of those locations, but it aims to close a combination of underperforming stores and stores that sit on valuable real estate.

Top 5 Performing Stocks To Invest In Right Now: Hanesbrands Inc.(HBI)


Advisors’ Opinion:

  • [By Paul Ausick]

    Hanesbrands Inc. (NYSE: HBI) dropped about 0.6% on Thursday to post a new 52-week low of $21.41 after closing at $21.53 on Wednesday. The stock’s 52-week high is $31.36. Volume was about a third the daily average of around 6 million shares. The company had no specific news Thursday.

  • [By Paul Ausick]

    Hanesbrands Inc. (NYSE: HBI) dropped about 0.3% on Monday to post a new 52-week low of $21.49 against a 52-week high of $31.36 and a Friday close of $21.55. Volume of about 3.8 million was 35% below the daily average of around 5.7 million. The company said on Friday that the company would sell some non-core assets.

  • [By Ben Levisohn]

    Hanesbrands (HBI) tumbled to the bottom of the S&P 500 today after missing earnings forecasts and offering disappointing guidance.

    Agence France-Presse/Getty Images

    Hanesbrandsdropped 16% to $18.98 today, while the S&P 500 rose 0.7% to 2,297.42.

    Stifel’s Jim Duffy and team explain what went wrong:

    Structural changes in US consumer and retail trends weighed on 4Q and HBI fell short in 4Q. These trends are expected to continue in FY17 and guidance was more cautious than prevailing estimates. Given the leverage and dependence on acquisitions for growth, we view visibility to underlying free cash generation key to valuation and we are discouraged by both 2016 results which were well short of plan and the outlook for FY17 operating cash flow which is a step backwards from prior FY16 guidance. With a reduction in 2017 CFO estimates from $795mn to $690mn we are lowering our 12-month target price from $26 to $23.


    Hanesbrands’ market capitalization fell to $7.2 billion today from $8.6 billion yesterday.

    Hanesbrands was just one of many retail companies that got shellacked this week. Under Armour (UAA) tumbled 29% after missing earnings forecasts and cutting its guidance, while Deckers Outdoor (DECK) plunged 21% after its earnings missed the Street consensus, and Ralph Lauren (RL) plummeted 13% after its CEO stepped down.

  • [By Paul Ausick]

    Hanesbrands Inc. (NYSE: HBI) dropped about 5.9% on Wednesday to post a new 52-week low of $21.50 after closing at $22.86 on Tuesday. The stock’s 52-week high is $31.36. Volume of about 31 million was more than 7 times the daily average of 4.5 million. The company had no specific news.

  • [By Paul Ausick]

    Hanesbrands Inc. (NYSE: HBI) dropped about 1.2% on Wednesday to post a new 52-week low of $21.44 after closing at $21.70 on Tuesday. The stock’s 52-week high is $31.36. Volume was about half the daily average of around 2.6 million shares. The company had no specific news Wednesday.

  • [By Rich Duprey]

    If a stock falls hard, particularly one with a durable name in its industry, it could be an opportunity to pick up shares on the cheap. But sometimes, a stock trades at a discount for a very good reason, so let’s take a look at Whirlpool (NYSE:WHR), Hanesbrands (NYSE:HBI), and Vista Outdoor (NYSE:VSTO) to see if they are good values at these lower prices — or just value traps.

Top 5 Performing Stocks To Invest In Right Now: Pacific Biosciences of California Inc.(PACB)


Advisors’ Opinion:

  • [By Paul Ausick]

    Pacific Biosciences of California Inc. (NASDAQ: PACB) slipped about 5.6% to post a new 52-week low of $2.52 Tuesday after closing at $2.67 on Friday. Volume of about 910,000 was about 10% above the daily average. The company had no specific news.

Top 5 Performing Stocks To Invest In Right Now: Silicon Graphics International Corp(SGI)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Cray Incstill and by far outperforming other supercomputer players likelarge caps International Business Machines Corp (NYSE: IBM) andHewlett-Packard Company (NYSE: HPQ) plus small cap Silicon Graphics International Corp (NASDAQ: SGI):

Top 5 Performing Stocks To Invest In Right Now: Texas Roadhouse, Inc.(TXRH)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Steakhouse chain Texas Roadhouse (NASDAQ:TXRH) has had to deal with an extremely difficult business environment for restaurant companies, and investors know all too well how tough times can hurt major players in the industry. Last quarter, Texas Roadhouse disappointed investors with sluggish results, and the company wanted to start 2017 on a better footing.

  • [By Demitrios Kalogeropoulos]

    As for individual stocks, Texas Roadhouse (NASDAQ:TXRH) and Garmin (NASDAQ:GRMN)made large moves following their quarterly earnings announcements.

  • [By Teresa Rivas]

    Texas Roadhouse(TXRH) tumbled more than 12% on Wednesday as itsfourth-quarter earningsand revenue fell short of expectations.

    Pixabay

    The restaurant chain said it earned 29 cents a share on revenue of $484.7 million. Analysts were expecting earnings per share of 38 cents on revenue of $497.3 million.


    Same-restaurant sales grew 1.2% at company restaurants and 2% at domestic franchises. For the first 55 days of the first quarter, Texas Roadhouse said that same-store sales rose 1.5%.

    The company also raised its dividend 10.5% to 21 cents a share.

    Some analysts urged investors to keep the faith in the stock.Barclay’s JeffreyBernsteinreiterated an Overweight rating and $47 price target on thestock:

    We believe TXRH fundamentals remain best-in-class. That said, the near-term focus remains on directional comps. And not unlike the broader industry, TXRH comps eased significantly to close 2016. Such led to disappointing 4Q16 results from top to bottom. Importantly, while the brand ‘is not immune’ to industry comp headwinds, the relative outperformance to the category was maintained. Looking to 2017, key guidance metrics were reiterated. While questions remain on whether the recent easing of industry comps will persist, we remain comforted by TXRH’s relative outperformance and easing comps as we move through 2017.


    Maxim’s Stephen Andersonreiterated a Buy rating, although he took his price target down $4, to $52:

    In our view, TXRH is not immune to the broader slowdown in Casual Dining, but we believe the company will emerge stronger than peers in the next few quarters.TXRHs disappointing 4Q16 comp of +1.3% (blended) was pulled down by a rare negative comp month in December (-2.1%), marking the first time this occurred in almost four years. Comps were +3% or better in both October and November, and comps so far in 1Q17 are positive despite a stormy start to the quarter in

Top 5 Performing Stocks To Invest In Right Now: Arena Pharmaceuticals, Inc.(ARNA)

Advisors’ Opinion:

  • [By Paul Ausick]

    Arena Pharmaceuticals Inc. (NASDAQ: ARNA) posted a new 52-week low of $1.20 on Tuesday, down about 19% compared with Monday’s closing price of $1.48. The stock’s 52-week high is $2.16. Volume was about 10% below the daily average of around 3.8 million shares. The company priced a secondary offering of 60 million shares at $1.15 per share, a path guaranteed to enrage existing investors.

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell by 0.09 percent. Meanwhile, top losers in the sector included Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), down 6 percent, and Omeros Corporation (NASDAQ: OMER), down 5 percent.

  • [By Peter Graham]

    The Q4 2016 earnings report for small cap obesity drug stock Arena Pharmaceuticals, Inc (NASDAQ: ARNA) is scheduled for after the market closes onTuesday (March 14th). Last June,Arena Pharmaceuticals announced a strategic shifting of priorities to emphasize its proprietary clinical stage pipeline and the implementation of additional cost reductions to streamline the organization to support its development programs. Among the actions to be taken is the layoff of 73% of the companys workforce which will cost approximately $6.1 million.

Leave a Reply

Your email address will not be published. Required fields are marked *